Oncology Brothers

GU Oncology Now

<p>Petros Grivas, MD, PhD, Clinical Director of the Genitourinary Cancer Program and a Professor in the Division of Medical Oncology at Fred Hutch Cancer Center, highlights the practice-changing and informing studies that have come out of the ASCO GU 2023 Symposium &ndash; including TALAPRO-2, TRITON3, CheckMate 274, and COSMIC-313, among others.</p>


Dr. Petros Grivas Shares the Practice Changing Studies From ASCO GU 2023

Petros Grivas, MD, PhD, highlights the practice-changing and informing studies that have come out of the ASCO GU 2023 Symposium.

Dr. Grivas on Practice Changing Studies From ASCO GU

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe